Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.
Mark Bensink, PhD, MSc, MEd
Advertisement
Articles by Mark Bensink, PhD, MSc, MEd
Advertisement
Latest Updated Articles
- The Long-term Social Value of Granulocyte Colony-Stimulating Factors
Published: October 4th 2019 | Updated:
Advertisement
Advertisement
